Skip to main content
menu

Management of ADHD in Autism Spectrum Disorder

Research Question:
Can ADHD be treated better in people with Autism Spectrum Disorder?

Basic Study Information

Purpose:
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by a high number neurodevelopmental and mental health challenges. Beyond the core features of ASD, children and adolescents on the autism spectrum also report higher rates of physical and mental health concerns, such as sleep problems, stomach issues, anxiety, and Attention Deficit/Hyperactivity Disorder (ADHD). This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are currently standard care. Your child may be eligible if they are 4 to 17 years old and have a confirmed diagnosis of ASD. Your child must also be able to take medication orally.

Location: University of Rochester
Study Reference #: STUDY00007536

Lead Researcher (Principal Investigator)

Lead Researcher:  Lynn Cole

Study Contact Information

Study Coordinator: Emily Wagner
Phone: (585) 276-2809
Email: Emily_wagner@urmc.rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search